{"title":"iga沉积肾病在儿科:临床方面和治疗方法","authors":"N.-M. Delos Santos , R.-J. Wyatt","doi":"10.1016/j.emcnep.2004.12.001","DOIUrl":null,"url":null,"abstract":"<div><p>The pediatric IgA nephropathies are IgA nephrothapy (Berger’s Disease) and Henoch-Schönlein purpura nephritis. Both conditions are reviewed in detail with respect to epidemiology, clinical features, outcome, prognostic markers, and therapeutic approaches. For both conditions variable disease severity and outcome along with the lack of conclusive evidence for efficacy of treatment based on randomized clinical trials makes it difficult to make strong recommendations regarding therapy.</p></div>","PeriodicalId":100433,"journal":{"name":"EMC - Néphrologie","volume":"2 1","pages":"Pages 12-30"},"PeriodicalIF":0.0000,"publicationDate":"2005-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.emcnep.2004.12.001","citationCount":"1","resultStr":"{\"title\":\"Néphropathies à dépôts d’IgA en pédiatrie : aspects cliniques et approches thérapeutiques\",\"authors\":\"N.-M. Delos Santos , R.-J. Wyatt\",\"doi\":\"10.1016/j.emcnep.2004.12.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>The pediatric IgA nephropathies are IgA nephrothapy (Berger’s Disease) and Henoch-Schönlein purpura nephritis. Both conditions are reviewed in detail with respect to epidemiology, clinical features, outcome, prognostic markers, and therapeutic approaches. For both conditions variable disease severity and outcome along with the lack of conclusive evidence for efficacy of treatment based on randomized clinical trials makes it difficult to make strong recommendations regarding therapy.</p></div>\",\"PeriodicalId\":100433,\"journal\":{\"name\":\"EMC - Néphrologie\",\"volume\":\"2 1\",\"pages\":\"Pages 12-30\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2005-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.emcnep.2004.12.001\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"EMC - Néphrologie\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1638624804000210\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"EMC - Néphrologie","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1638624804000210","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Néphropathies à dépôts d’IgA en pédiatrie : aspects cliniques et approches thérapeutiques
The pediatric IgA nephropathies are IgA nephrothapy (Berger’s Disease) and Henoch-Schönlein purpura nephritis. Both conditions are reviewed in detail with respect to epidemiology, clinical features, outcome, prognostic markers, and therapeutic approaches. For both conditions variable disease severity and outcome along with the lack of conclusive evidence for efficacy of treatment based on randomized clinical trials makes it difficult to make strong recommendations regarding therapy.